Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
OBJECTIVE
To determine the prevalence of the metabolic syndrome (MetS) and its components in Brazilian women with polycystic ovary syndrome (PCOS).


METHODS
Cross-sectional study.


METHODS
University Hospital, Federal University of Rio Grande do Norte, Natal-RN, Brazil.


METHODS
102 women with PCOS by the Rotterdam consensus criteria.


METHODS
None.


METHODS
Clinical and biochemical parameters for MetS as defined by the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III).


RESULTS
The prevalence for individual components of MetS were high-density lipoprotein cholesterol level <50 mg/dL in 69.6%, waist circumference >or=88 cm in 57.9%, triglyceride level >or=150 mg/dL in 31.7%, blood pressure >or=130/85 mm Hg in 18.6%, and fasting glucose concentrations >or=110 mg/dL in 2.9%. Three or more of these individual criteria were present in 29 (28.4%) of the patients. The prevalence of MetS increased with body mass index: 3.2%, 19.2% and 52.3% for normal, overweight, and obese women, respectively.


CONCLUSIONS
These findings indicate that Brazilian women with PCOS have a high prevalence of MetS and its individual components, particularly a decreased high-density lipoprotein cholesterol level. Thus, these women are at increased risk of diabetes mellitus and cardiovascular disease.
Soares
Elvira Maria Mafaldo
EM
Departamento de Tocoginecologia, Maternidade Escola Januário Cicco, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil.
Azevedo
George Dantas
GD
Gadelha
Rafael Gonçalves Nóbrega
RG
Lemos
Telma Maria Araújo Moura
TM
Maranhão
Técia Maria Oliveira
TM
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D001938:Brazil / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D008076:Cholesterol, HDL / Q000097:blood; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D050171:Dyslipidemias / Q000097:blood / Q000453:epidemiology; D005260:Female; D018149:Glucose Intolerance / Q000097:blood / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000503:physiopathology; D009765:Obesity / Q000097:blood / Q000453:epidemiology; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications / Q000453:epidemiology* / Q000503:physiopathology; D015995:Prevalence; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D008076:Cholesterol, HDL; D014280:Triglycerides